MedPath

Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis

Phase 1
Completed
Conditions
Cystic Fibrosis
Insulin-dependent Diabetes
Diabetes Related Cystic Fibrosis
Interventions
Procedure: Combined pancreatic islet and lung transplantation
Registration Number
NCT01548729
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Patients with end-stage cystic fibrosis (CF) and severe CF-related diabetes (CFRD) may benefit from combined lung-pancreatic islet transplantation. A recent case series showed that combined bilateral lung and pancreatic islet transplantation is a viable therapeutic option for patients with end-stage CF and CFRD. The use of different organs from a single donor may lead to reduced immunogenicity. As the prevalence of CFRD has increased dramatically with the improved life expectancy of patients with CF, islet transplantation should be considered at the end-stage CF. By restoring metabolic control, the investigators hypothesize that islet transplantation may improve the management of CF patients undergoing lung transplant and decrease the complication rate in the early postoperative period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patient with cystic fibrosisCombined pancreatic islet and lung transplantationPatients with end-stage cystic fibrosis
Primary Outcome Measures
NameTimeMethod
Metabolic efficiency at 1 year1 year

Combined criteria based on the 4 following criteria: weight increase \> 5% compared to inclusion, fasting blood glucose \< 1.1 g/l at 12 months post-transplant (beta score criterion), Reducing insulin requirements (expressed in UI/day) compared to inclusion \& decreased in HbA1c \>= 0.5% (in absolute value) compared to inclusion Success is defined by achieving at least three of these criteria

Secondary Outcome Measures
NameTimeMethod
HbA1cEvery 3 months during 1 year after transplant
Ratio [C-peptide stimulated T6min/ C-peptide basal T0]Every 3 months during 1 year after transplant
Tiffeneau-Pinelli indexEvery month during 1 year after transplant

FEV1/FVC

Nature of pulmonary infection episodes and nature of acute lung rejection if need beEvery month during 1 year after transplant
Oxygen saturation SaO2 room airEvery month during 1 year after transplant
Adverse eventsEvery visit during 1 year after transplant
C-peptide stimulated by glucagonEvery 3 months during 1 year after transplant
Insulin requirementsEvery month during 1 year after transplant

Unit/day

Number of minor hypoglycemiaEvery month during 1 year after transplant

defined by a blood glucose level \< 0.6g/L at which the patient is capable of self-sugaring

Forced Vital Capacity (FVC)Every month during 1 year after transplant
Microalbuminuria & proteinuriaEvery 3 months during 1 year after transplant
Median maximum expiration flowEvery month during 1 year after transplant
Number of days of post-transplant hospitalization and during the follow-upEvery visit during 1 year after transplant
Forced Expiratory Volume (FEV1)Every month during 1 year after transplant
Number of episodes of pulmonary rejectionEvery visit during 1 year after transplant

requiring a corticosteroid bolus

MortalityEvery visit during 1 year after transplant
Ratio [C-peptide/Glucose-Creatinine] & ratio [C-peptide/Glucose]Every week during the first month, and every month during 1 year
Number of major hypoglycemiaEvery month during 1 year after transplant
Glycemic variability (MAGE)Every 6 months during 1 year after transplant

by continuous glycemic measurement Holter (CGMS) \& glycemic reader memory analysis

duration of hypoglycemiaEvery 6 months during 1 year after transplant

by continuous glycemic measurement Holter (CGMS) \& glycemic reader memory analysis

Dyspnea score according to the mMRC scaleEvery month during 1 year after transplant

Trial Locations

Locations (28)

Service de Radiologie Interventionnelle, CHU de Grenoble

🇫🇷

Grenoble, France

Service de Chirurgie Thoracique, HOPITAL LOUIS PRADEL

🇫🇷

Lyon, France

Service d'Endocrinologie, Pavillon médical

🇫🇷

Lyon, France

Service de Pneumologie - Hôpital Foch

🇫🇷

Suresnes, France

Service de Pneumologie

🇫🇷

Nantes, France

Service d'Anesthésie-Réanimations chirurgicales, Nouvel Hôpital Civil

🇫🇷

Strasbourg, France

Service de Radiologie, Hôpital de Hautepierre

🇫🇷

Strasbourg, France

CRCM adulte, Centre Hospitalier Lyon-Sud

🇫🇷

Lyon, France

Service de la Clinique d'Endocrinologie, maladies métaboliques et Nutrition

🇫🇷

Nantes, France

Service d'Imagerie - Hôpital Foch

🇫🇷

Suresnes, France

Service de pneumologie, Hôpital Louis Pradel

🇫🇷

Lyon, France

Service d'Anesthésie-Réanimations Chirurgicales

🇫🇷

Strasbourg, France

Service de Radiologie

🇫🇷

Nantes, France

Service de pneumologie, Nouvel Hôpital Civil

🇫🇷

Strasbourg, France

CRCM AdulteCHU de Grenoble, Hôpital A. Michallon

🇫🇷

Grenoble, France

Nephrologie, CHU Grenoble

🇫🇷

Grenoble, France

Réanimation Cardiovasculaire et Thoracique, Hôpital Michallon

🇫🇷

Grenoble, France

Service de Chirurgie Cardiaque, CHU Grenoble

🇫🇷

Grenoble, France

Service d'Endocrinologie, CHU de Grenoble

🇫🇷

Grenoble, France

Service de Pneumologie, Hôpital A. MICHALLON , CHU de Grenoble

🇫🇷

Grenoble, France

Service de médecine de la transplantation et immunologie clinique, Hôpital Edouard Herriot

🇫🇷

Lyon, France

Service d'Urologie et chirurgie de la Transplantation, Groupement Hospitalier Edouard Herriot

🇫🇷

Lyon, France

Service d'imagerie radiologique et de médecine nucléaire, Centre Hospitalier Lyon-Sud

🇫🇷

Lyon, France

Service de Néphrologie et Immuno-transplantation

🇫🇷

Nantes, France

Service d'endocrinologie, diabète et maladies métaboliques

🇫🇷

Strasbourg, France

Service de chirurgie, Nouvel Hôpital Civil

🇫🇷

Strasbourg, France

Unité d'Endocrinologie, Diabétologie et Médecine Métabolique - Hôpital Foch

🇫🇷

Suresnes, France

Service de Chirurgie Thoracique et Transplantation Pulmonaire - Hôpital Foch

🇫🇷

Suresnes, France

© Copyright 2025. All Rights Reserved by MedPath